Seoul National University Hospital to Develop Mobile Hemodialysis Medical Device

Seoul (G-MedTech) — Seoul National University Hospital (a team of professor Kim Dong-ki) and Seoul Medical University (a team of professor Lee Jeong-chan in the Department of Medicine) announced on the 29th that they would start a hemodialysis device and filter development project together with HealthConnect, Synopex, and Bayada Home Healthcare.

Hemodialysis, which accounts for more than 80% of all renal replacement therapies, is the treatment that uses the most finances from health insurance among single medical practices. However, until now, hemodialysis equipment, filters, and consumables had to be entirely imported.

According to the National Health Insurance Service, more than 2.7 trillion won ($2.1 billion) was spent on hemodialysis last year. Accordingly, there has been a continuous demand for locally developed equipment to reduce health insurance finances.

To solve these problems, a team led by Professors Kim Dong-ki and Lee Jeong-chan will start research to develop a home dialysis patient monitoring system using hemodialysis filters, portable hemodialysis equipment, water purification systems, and ICT technology to establish a medical service model based on visiting nursing. This research will be conducted over the next four years with the support of the Pan-Ministry of Health and Welfare Medical Device Research and Development Project Group.

The mobile hemodialysis medical device will not only be able to perform dialysis treatment without interruption even in emergencies such as a pandemic but also help patients with smooth economic activities by flexibly adjusting the dialysis time. We expect that the prognosis of patients will be improved through individualized dialysis prescription.

Professor Kim Dong-ki, Seoul National University Hospital

Synopex R&D Center Director Yu-min Yu and HealthConnect CEO Lim Dong-seok said, “Based on our global IT technology competitiveness and experience in developing various filter materials, we will actively promote overseas export as well as localization of hemodialysis medical devices.”